Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Aditxt Inc ADTX

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:ADTX)

Aditxt Provides Updates on its Growth Vision for bitXbio(TM), Planned Digital Asset Treasury, Pearsanta's Planned IPO, And Evofem's Plan to Regain a National Listing

Business Wire November 18, 2025

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025

Business Wire October 29, 2025

Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market

Business Wire October 27, 2025

Evofem Announces Voting Results from Special Meeting of Stockholders

PR Newswire October 20, 2025

Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms

PR Newswire September 11, 2025

Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting

PR Newswire September 9, 2025

Aditxt's Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

Business Wire August 25, 2025

Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law

PR Newswire August 21, 2025

Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio(TM) Initiative

Business Wire August 11, 2025

Opinion & Analysis (NDAQ:ADTX)

No current opinion is available.

Bullboard Posts (NDAQ:ADTX)

Buy buddy buy because it's taking off this morning.

Otherwise FOMO for you fellas out there today anyway,so good luck to all of you guys
coolfooldumbguy - 8 days ago

$ADTX get in early imo!

................................
stock2watch1 - August 13, 2025

RE: Next Super Stock (NASDAQ: ADTX) CEO livestream - Pearsanta

https://www.youtube.com/live/z6h86_B3EME
stock2watch1 - July 18, 2025

Next Super Stock (NASDAQ: ADTX) CEO livestream - Pearsanta

<< View Post To Watch Video >>
stock2watch1 - July 18, 2025

$ADTX - Big bounce coming check it out

.................... 
stock2watch1 - July 16, 2025

Sold out of this stock yesterday.

It was my mistake for selling it too soon,but I didn't know that it was going to go up more today and didn't want to be too...
coolfooldumbguy - March 20, 2025